Analgesics in the Middle East and Africa faces challenges against the backdrop economic slowdown. Self-medication, generics and product innovation have positively influenced demand, but lower consumer confidence and economic turmoil in key markets have had a negative impact. Growth potential remains high, with typically low per capita usage across the region, but the onset of COVID-19 can be expected to intensify and exacerbate economic problems.
This report comes in PPT.
The Middle East and Africa is increasingly characterised by rising product awareness, with a widening availability of brands across price points and quality. Consumers are increasingly stocking up on analgesics for relief of common ailments. Well-trusted brands such as Panadol have done much to raise awareness of analgesics for pain relief and the treatment of flu-related symptoms.
African countries such as Egypt and South Africa can suffer from overburdened public health systems, which is further fuelling the trend towards self-medication.
High value markets in the Middle East, such as Saudi Arabia and the United Arab Emirates face real economic challenges, such as falling oil prices, and government-led initiatives resulting in the departure of expatriates from both countries. COVID-19 has also cast a dark shadow over economic prospects; tourism, for example, has been hit hard in 2020.
Developing economies in the African and Sub-Saharan region are benefiting from increased usage of inexpensive analgesic brands, such as Adcock Ingram’s Panado in South Africa.
Topical analgesics is expected to witness 6% forecast CAGR versus 3.5% in systemic analgesics, as consumers start to balance usage among the two, partially due to rising awareness of side effects of frequent long-term usage of oral analgesics. Systemic analgesics will still dominate in terms of actual US dollar value gains, however.
It is the aggregation of OTC, Vitamins and Dietary Supplements (VDS), Sports Nutrition, and Weight Management and Wellbeing
See All of Our DefinitionsIf you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!